Literature DB >> 8158755

Factors influencing adrenal metastasis in renal cell carcinoma.

A I Sagalowsky1, K T Kadesky, D M Ewalt, T J Kennedy.   

Abstract

The factors predisposing to adrenal metastasis in renal cell carcinoma were reviewed in 695 cases. The overall incidence of adrenal metastasis was 4.3%. The risk of adrenal metastasis correlated with tumors that were on the left side, large and replacing the entire kidney, upper pole in location and of advanced T stage. Nevertheless, microscopic and/or contralateral adrenal metastasis was noted in patients with smaller, lower pole or mid renal tumors. Of 30 patients with adrenal metastasis 9 (30%) had clinical evidence of widespread disease. Among the patients who underwent complete surgical resection 14% had either positive lymph nodes or other non-adrenal metastases. Of the patients undergoing resection 81% died, with a mean postoperative survival of 27 months. Sustained disease-free survival was noted in 3 patients (0.43% of the entire series) whose complete pathological staging was pT1-3b, N0, M0. The need and benefit of adrenalectomy during surgery for renal cell carcinoma are extremely limited.

Entities:  

Mesh:

Year:  1994        PMID: 8158755     DOI: 10.1016/s0022-5347(17)35208-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Radical surgery for renal-cell carcinoma: caval neoplastic excision, adrenalectomy, lymphadenectomy, adjacent organ resection.

Authors:  F F Marshall; G D Steinberg; C R Pound; A W Partin
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

2.  Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal.

Authors:  Alexander Kutikov; Zachary J Piotrowski; Daniel J Canter; Tianyu Li; David Y T Chen; Rosalia Viterbo; Richard E Greenberg; Stephen A Boorjian; Robert G Uzzo
Journal:  J Urol       Date:  2011-02-22       Impact factor: 7.450

3.  Clinical and prognostic factors for renal parenchymal, pelvis, and ureter cancers in SEER registries: collaborative stage data collection system, version 2.

Authors:  Sean F Altekruse; Lois Dickie; Xiao-Cheng Wu; Mei-Chin Hsieh; Manxia Wu; Richard Lee; Scott Delacroix
Journal:  Cancer       Date:  2014-12-01       Impact factor: 6.860

Review 4.  Oncological and renal medical importance of kidney-sparing surgery.

Authors:  Paul Russo
Journal:  Nat Rev Urol       Date:  2013-03-05       Impact factor: 14.432

Review 5.  Factors influencing adrenal metastasis in renal cell carcinoma.

Authors:  S M Moudouni; I En-nia; A Manunta; F Guillé; B Lobel
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 6.  Adrenal sparing surgery in the treatment of renal cell carcinoma: when is it possible?

Authors:  R Autorino; G Di Lorenzo; R Damiano; S Perdonà; A Oliva; M D'Armiento; M De Sio
Journal:  World J Urol       Date:  2003-07-12       Impact factor: 4.226

Review 7.  Surgical management of renal cell carcinoma.

Authors:  Laura-Maria Krabbe; Aditya Bagrodia; Vitaly Margulis; Christopher G Wood
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

8.  Synchronous renal cell carcinoma metastasis to the contralateral adrenal gland and pancreas: A case report with 7-year follow-up subsequent to surgical therapy.

Authors:  Cunzao Wu; Zhenxu Zhou; Xueting Ye; Weilie Hu
Journal:  Oncol Lett       Date:  2016-04-28       Impact factor: 2.967

9.  Renal cell carcinoma with bilateral synchronous adrenal gland metastases: a case report.

Authors:  Georgios E Koutalellis; Evangelos Felekouras; Constantinos Evangelou; Georgios Koritsiadis; Dimitrios Chasiotis; Ioannis Anastasiou
Journal:  Cases J       Date:  2009-09-09

Review 10.  Should laparoscopy be the standard approach used for radical nephrectomy?

Authors:  A J Portis; R V Clayman
Journal:  Curr Urol Rep       Date:  2001-04       Impact factor: 2.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.